Home › Funds › Octagon Capital Advisors LP › DNTH
Octagon Capital Advisors LP position in DNTH
DIANTHUS THERAPEUTICS INC · Health Care
Octagon Capital Advisors LP reported holding 1,841,667 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$179.5M, representing 16.14% of its reported portfolio and ranking #1 among its reported holdings. Octagon Capital Advisors LP has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's DNTH position evolved
Octagon Capital Advisors LP first disclosed a stake in DNTH in Q3 2023 at 480,000 shares (US$6.6M). The position peaked in Q2 2026 at 1,841,667 shares, worth US$179.5M. Across 12 filings, Octagon Capital Advisors LP increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,841,667 shares valued at US$179.5M — a reduction of -105,000 shares quarter over quarter.. Notable position changes include a 149% increase in Q1 2024 (shares fell 14% over the following quarter), a 27% increase in Q2 2024 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 480.00K | $6.56M | New |
| Q4 2023 | 554.00K | $5.76M | Add |
| Q1 2024 | 1.38M | $41.42M | Add |
| Q2 2024 | 1.75M | $45.20M | Add |
| Q3 2024 | 1.75M | $47.82M | Hold |
| Q4 2024 | 2.11M | $46.00M | Add |
| Q1 2025 | 2.34M | $42.48M | Add |
| Q2 2025 | 2.34M | $43.63M | Hold |
| Q3 2025 | 2.42M | $95.10M | Add |
| Q4 2025 | 2.42M | $99.59M | Hold |
| Q1 2026 | 1.95M | $163.36M | Reduce |
| Q2 2026 | 1.84M | $179.53M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNTH and 13F data
DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), TCG Crossover Management, LLC (US$163.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNTH
- Fairmount Funds Management LLC 2.54M sh · $247.33M · Q2 2026
- Avidity Partners Management LP 2.10M sh · $205.12M · Q2 2026
- TCG Crossover Management, LLC 1.68M sh · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M sh · $126.97M · Q2 2026
- Venrock Adviser, LLC 1.18M sh · $115.03M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.13M sh · $109.70M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K sh · $83.07M · Q2 2026
- Logos Global Management LP 800.00K sh · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K sh · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K sh · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K sh · $40.94M · Q2 2026
- Affinity Asset Advisors, LLC 400.00K sh · $38.99M · Q2 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held DNTH?
Octagon Capital Advisors LP has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Octagon Capital Advisors LP's current position in DNTH?
As of Q2 2026, Octagon Capital Advisors LP holds 1.84M shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $179.53M, representing 16.14% of its reported portfolio and ranking #1.
Has Octagon Capital Advisors LP been buying or selling DNTH?
In the latest 13F filing (Q2 2026), Octagon Capital Advisors LP reduced its position in DNTH. The position peaked in Q2 2026 at 1.84M shares.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, TCG Crossover Management, LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.